Early studies showed that BRCA carriers had better odds of surviving ovarian cancer than do women without these mutations. The National Cancer Institute has how done a large meta-analysis of the existing studies to date which confirms this survival benefit. Women with BRCA2 mutations have the highest odds of surviving ovarian cancer although BRCA1 carriers have better odds than women without mutations. The following video explains this new study and future research in this area.
Click here to view the video.
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. Inquiries regarding rights should be directed to the authors.